EVOFEM BIOSCIENCES
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products. The company's first commercial product, Phexxi®, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
EVOFEM BIOSCIENCES
Industry:
Biopharma Health Care Medical Women's
Founded:
2009-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.evofem.com
Total Employee:
101+
Status:
Active
Contact:
+858.550.1900
Email Addresses:
[email protected]
Total Funding:
470.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Agile Therapeutics
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-01-17 | Neothetics | Neothetics acquired by Evofem Biosciences | N/A |
Investors List
Keystone Capital
Keystone Capital investment in Post-IPO Equity - Evofem Biosciences
Adjuvant Capital
Adjuvant Capital investment in Post-IPO Debt - Evofem Biosciences
PDL Biopharma
PDL Biopharma investment in Post-IPO Equity - Evofem Biosciences
PDL Biopharma
PDL Biopharma investment in Post-IPO Equity - Evofem Biosciences
Woodford Investment Management
Woodford Investment Management investment in Post-IPO Equity - Evofem Biosciences
Domain Associates
Domain Associates investment in Series C - Evofem Biosciences
AKS Capital
AKS Capital investment in Series C - Evofem Biosciences
Alta Partners
Alta Partners investment in Series C - Evofem Biosciences
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series C - Evofem Biosciences
RUSNANO
RUSNANO investment in Series C - Evofem Biosciences
Official Site Inspections
http://www.evofem.com Semrush global rank: 1.24 M Semrush visits lastest month: 24.44 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Evofem Biosciences"
About Us - Evofem Biosciences, Inc.
Mailing Address: 7770 Regents Road Suite 113-618 San Diego, California 92122 1.858.550.1900. Headquarters: 12636 High Bluff Drive, Suite 400 San Diego, CA 92130See details»
Evofem Biosciences - Crunchbase Company Profile & Funding
Organization. Evofem Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Evofem is a biopharmaceutical …See details»
Evofem Biosciences Management Team - Saundra Pelletier, CEO
She joined Evofem as Chief Financial Officer and Secretary in April 2023 and leads the Company’s finance organization and financial activities including financial planning and …See details»
Evofem Company Profile | Management and Employees List
Evofem Profile and History. Evofem, Inc. is a privately-owned biotechnology company founded in 2007 and based out of San Diego, CA. Evofem develops contraceptives and global products …See details»
Evofem Biosciences - LinkedIn
Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in …See details»
Evofem Biosciences Company Profile 2024: Valuation, Investors ...
Evofem Biosciences General Information Description. Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative …See details»
Evofem Biosciences, Inc. - AnnualReports.com
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in …See details»
Evofem Biosciences Company Description - Stock Analysis
Oct 2, 2024 Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive …See details»
Evofem - Overview, News & Similar companies | ZoomInfo.com
Apr 18, 2024 Evofem Biosciences Announces Financial Results for the First Quarter of 2024 SAN DIEGO, May 15, 2024 /PRNewswire/ -- The company behind the hormone-free …See details»
Evofem Biosciences - Funding, Financials, Valuation & Investors
Evofem Biosciences is registered under the ticker OTCQB:EVFM . Evofem Biosciences is funded by 16 investors. Aditxt Therapeutics and Keystone Capital are the most recent investors. …See details»
Corporate Mission - Evofem Biosciences, Inc.
Evofem’s sole purpose is to improve the quality of lives of women worldwide by. providing them with more control over their sexual and reproductive health. We are passionately committed to …See details»
Evofem Biosciences Company Profile - Office Locations ... - Craft
Jul 12, 2024 Evofem Biosciences has 3 employees at their 1 location and $18.22 m in annual revenue in FY 2023. See insights on Evofem Biosciences including office locations, …See details»
Revolutionizing Women’s Sexual and Reproductive Health
10 ©2019 Evofem Biosciences, Inc.©2020 Evofem Biosciences, Inc. Preparing for Approval and Launch 98% of the most important prescribers are OB/GYN specialists1,2 Sales Force Build …See details»
Revolutionizing Women’s Sexual and Reproductive Health
Feb 15, 2022 •Evofem’sability to obtain the necessary regulatory approvals for its product candidates and the timing of such approvals, and, •Any other risk factors detailed in Evofem’s …See details»
Evofem, Inc. Company Profile | San Diego, CA - Dun & Bradstreet
Company Description: Evofem (formerly Instead) hopes that women adopt its alternative to pads and tampons. Its primary product, the Instead Softcup, is a feminine hygiene product that sits …See details»
Evofem - Company Profile - Tracxn
Oct 21, 2024 Evofem ranks 1st among 110 active competitors. 31 of its competitors are funded while 20 have exited. Overall, Evofem and its competitors have raised over $2.61B in funding …See details»
EVFM Board of Directors - Evofem Biosciences, Inc.
Tony O’Brien. Mr. O’Brien has served as a member of the Evofem Biosciences board of directors since January 2018. He served as the Director General of Ireland’s Health Service Executive, …See details»
Working At Evofem Biosciences: Company Overview and Culture
Learn about working at Evofem Biosciences from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. ... Organization Type. Public. …See details»
Ottawa names new president and CEO of Export Development …
2 days ago Abdelmessih says Lavery's "vision and commitment have significantly expanded EDC's impact and relevance to Canadian companies" and the outgoing CEO set a high …See details»
Ivy Zhang - Evofem Biosciences, Inc.
Ivy Zhang is a trusted leader who is dedicated to advancing Evofem Biosciences’ mission of addressing the unmet sexual and reproductive health needs of women. She joined Evofem as …See details»